Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

83.90p
   
  • Change Today:
    -1.25p
  • 52 Week High: 159.80
  • 52 Week Low: 67.00
  • Currency: UK Pounds
  • Shares Issued: 961.94m
  • Volume: 4,267,638
  • Market Cap: £807.06m

Dr Martens shares in the red amid slowing sales growth, declining APAC sales

By Iain Gilbert

Date: Thursday 27 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Shares in bootmaker Dr Martens slumped early on Thursday despite it posting third-quarter group revenues that were in line with internal expectations amid slowing sales growth and a significant drop in sales across the Asia-Pacific region.
Dr Martens said Q3 group revenues were up 11% year-on-year at £307.0m, as the third quarter, typically its strongest direct-to-consumer period, saw it deliver DTC revenue growth of 33%, with eCommerce growing strongly alongside a "very good recovery" in retail, resulting in an improved DTC mix of 64%.

However, the prioritisation of inventory into its DTC channel, due to the impact of Covid-19 on both manufacturing and global shipping, led to a lower performance in its wholesale division, with revenues down 14% in the quarter.

The FTSE 250-listed firm added that by region, Europe, the Middle East and Africa recorded "strong growth", while the Americas delivered a solid third quarter with "a very good" DTC performance being partially offset by wholesale woes.

Asia-Pacific revenues, on the other hand, were impacted by renewed Covid restrictions across the region, declining 28%.

Looking forward, Dr Martens said it was confident in achieving market expectations for its first full year as a listed business, assuming no significant Covid impacts in the fourth and final quarter.

Chief executive Kenny Wilson said: "We delivered a good performance during our largest quarter, with direct-to-consumer revenues growing 33% versus Q3 last year to 64% revenue mix.

"We continued to put our long-term custodian approach at the heart of decision making and proactively managed the business against a changing Covid backdrop, prioritising the higher margin DTC channels in line with our strategy. We remain confident in achieving market expectations for the full year."

As of 0910 GMT, Dr Martens shares are down 12.08% at 284.16p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 83.90p
Change Today -1.25p
% Change -1.47 %
52 Week High 159.80
52 Week Low 67.00
Volume 4,267,638
Shares Issued 961.94m
Market Cap £807.06m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.20% above the market average57.20% above the market average57.20% above the market average57.20% above the market average57.20% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Price Trend
77.39% below the market average77.39% below the market average77.39% below the market average77.39% below the market average77.39% below the market average
53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average
Income
65.03% above the market average65.03% above the market average65.03% above the market average65.03% above the market average65.03% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
2% below the market average2% below the market average2% below the market average2% below the market average2% below the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 04-Jan-24 08-Jun-23
Paid 02-Feb-24 18-Jul-23
Amount 1.56p 4.28p

Trades for 29-May-2024

Time Volume / Share Price
16:35 821,898 @ 83.90p
16:35 1 @ 83.90p
16:35 862 @ 83.90p
16:35 256 @ 83.90p
16:35 4,487 @ 83.90p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson
CFO Giles Wilson

Top of Page